In lupus patients, latent Epstein-Barr virus can reprogram B cells and send the body’s immune response into overdrive, resulting in widespread inflammation. The Epstein-Barr virus (EBV) has been ...
Scientists have found the clearest evidence yet that Epstein-Barr virus (EBV) – which nearly all of us carry for life – is ...
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant ...
The UK is launching a groundbreaking Horizon trial to see if a vaccine can help people with multiple sclerosis by targeting the Epstein-Barr virus (EBV), a virus found in almost all MS patients. Led ...
A new trial will test whether an mRNA jab to protect against a common virus found in almost all people with multiple sclerosis (MS) could treat ...
A new trial is to take place at 10 UK locations involving patients diagnosed with multiple sclerosis (MS). It is set to investigate whether a vaccine designed to protect against a common virus found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback